Usefulness of Minocycline-based quadruple therapy for management of H. pylori

Summaries 2 min 609

Font Size

Created On: 24/01/2024

A meta-analysis was conducted to compare and consolidate the safety and effectiveness of Helicobacter pylori (H. pylori) quadruple regimens, both with and without the inclusion of Minocycline.

See All

Key take away

Minocycline quadruple therapy is safe and effective for eradicating H. pylori.

Background

A meta-analysis was conducted to compare and consolidate the safety and effectiveness of Helicobacter pylori (H. pylori) quadruple regimens, both with and without the inclusion of Minocycline.

Method

To identify treatment regimens involving Minocycline quadruple therapy for the elimination of H. pylori and the assessment of associated adverse events (AEs), a literature search was carried out using databases such as the Cochrane Library and PubMed. The control group comprised volunteers receiving alternative treatments with no Minocycline.

Result

This meta-analysis encompassed five randomized controlled clinical trials involving 2004 individuals. The H. pylori elimination rate achieved with Minocycline quadruple therapy was comparable to the control therapy (Odds ratio [OR] 1.25, I2 = 0%) in intention-to-treat (ITT) analysis, as shown in Table 1:

When comparing Minocycline-based regimens specifically with those containing Tetracycline, there was no discernible difference in the elimination rate (85.5% vs. 85.5%, OR 1.00). However, when contrasting Minocycline regimens with those devoid of Tetracycline, the former exhibited significant superiority (82.7% vs. 77.2%; OR, 1.40). The occurrence of AEs in the Minocycline quadruple therapy group was comparable to the control group (35.9% vs. 38.8%, OR 0.88, I2 = 13%).

Conclusion

The Minocycline quadruple therapy showed favorable efficacy and safety profile in eliminating H. pylori, suggesting it could be considered as an alternative treatment.